Association of Circulating Carbohydrate Antigen 19-9 Level with Type 2 Diabetic Kidney Disease in Chinese Adults: A Cross-Sectional Study
Pijun Yan,Jia Li,Yi Zhang,Xiaofang Dan,Xian Wu,Xing Zhang,Yuxia Yang,Xiping Chen,Shengxi Li,Pan Chen,Qin Wan,Yong Xu
DOI: https://doi.org/10.2147/dmso.s434972
2024-01-31
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Pijun Yan, 1– 5 Jia Li, 1– 5 Yi Zhang, 1– 5 Xiaofang Dan, 1– 5 Xian Wu, 1– 5 Xing Zhang, 1– 5 Yuxia Yang, 1– 5 Xiping Chen, 6 Shengxi Li, 6 Pan Chen, 1– 5 Qin Wan, 1– 5 Yong Xu 1– 5 1 Department of Endocrinology and Metabolism, the Affiliated Hospital of Southwest Medical University, Luzhou, People's Republic of China; 2 Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, People's Republic of China; 3 Sichuan Clinical Research Center for Diabetes and Metabolism, Luzhou, People's Republic of China; 4 Sichuan Clinical Research Center for Nephropathy, Luzhou, People's Republic of China; 5 Cardiovascular and Metabolic Diseases Key Laboratory of Luzhou, Luzhou, People's Republic of China; 6 Clinical medical College, Southwest Medical University, Luzhou, People's Republic of China Correspondence: Pijun Yan, Department of Endocrinology and Metabolism, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China, Tel/Fax +86-830-3165361, Email Objective: Very few and conflicting data are available regarding the correlation between circulating carbohydrate antigen 19-9 (CA19-9) levels and diabetic kidney disease (DKD) and its components including albuminuria and a low estimated glomerular filtration rate (eGFR). This study aimed to examine the association of circulating CA19-9 and DKD in Chinese patients with type 2 diabetes mellitus (T2DM). Methods: A total of 402 hospitalized T2DM patients between September 2017 and December 2021 were included in this cross-sectional study. There were 224 and 178 subjects in non-DKD and DKD groups, respectively. Serum CA19-9 was measured by chemiluminescence method, and its potential relationship with DKD was evaluated by multivariate logistic regression and correlation analyses, and receiver operating characteristic (ROC) curve analysis. Results: T2DM patients with DKD had significantly higher serum CA19-9 levels than those without, and serum CA19-9 levels were positively related to urinary albumin-to-creatinine ratio and negatively to eGFR ( P < 0.01). Multivariate regression analysis revealed that serum CA 19-9 was an independent factor of DKD [odds ratio (OR), 1.018; 95% confidence interval (CI), 1.002– 1.035; P < 0.05]. Moreover, an increased progressively risk of DKD with an increase in serum CA19-9 quartiles was observed ( P for trend < 0.001), and T2DM patients in the highest serum CA19-9 quartile were associated with an increased likelihood of DKD when compared to those in the lowest quartile (OR: 2.936, 95% CI 1.129– 7.633, P < 0.05). Last, the analysis of ROC curves suggested that serum CA 19-9 at a cut of 25.09 U/mL resulted in the highest Youden index with sensitivity 43.8% and 75.4% specificity to predict the presence of DKD. Conclusion: These results showed that high circulating CA19-9 was related to DKD and may serve as a useful biomarker of DKD in hospitalized Chinese T2DM patients. Keywords: carbohydrate antigen 19-9, urinary albumin-to-creatinine ratio, diabetic kidney disease, estimated glomerular filtration rate, Chinese population Diabetic kidney disease (DKD) is one of the most common and intractable microvascular complications that occurs in approximately 25–40% of diabetic patients worldwide. 1,2 It is well established that DKD is not only the main cause of end-stage renal disease worldwide, 1 but also the leading cause of cardiovascular disease and all-cause mortality in diabetic patients, 3,4 which imposes a considerable burden on healthcare systems and patients. Currently, albuminuria has been still considered to be a primary indicator of the onset or progression of DKD, yet albuminuria lacks the necessary sensitivity and specificity to accurately predict the development and progression of DKD in patients with type 2 diabetes mellitus (T2DM) 5,6 because albuminuria is susceptible to many factors, such as infection, fever, exercise, diet, menstruation, 7 and progressive nephropathy and renal impairment can occur in certain diabetic individuals who exhibit normal urinary albumin levels. 6 Therefore, identification of new, non-invasive biomarkers for early diagnosis of DKD is imminent so as to better detect high-risk patients for early intervention. Carbohydrate antigen 19-9 (CA19-9) is a tumor-associated antigen originally isolated from a human colorectal cancer cell line as a mucin-like product by Koprowski et al in 1976. 8,9 CA19-9 was expressed in some tissues, including pancreatic cells, in the normal human body -Abstract Truncated-
endocrinology & metabolism